[HCA LOGO]                                                        NEWS

                                                          FOR IMMEDIATE RELEASE

INVESTOR CONTACT:                                            MEDIA CONTACT:
Mark Kimbrough                                               Jeff Prescott
615-344-2688                                                 615-344-5708


                         HCA SIGNS PREVIOUSLY ANNOUNCED
                     SETTLEMENT AGREEMENTS WITH DOJ AND CMS


NASHVILLE, TENN., JUNE 26, 2003--HCA (NYSE-HCA) today announced that the company
and the U.S. Department of Justice have signed agreements to settle litigation
brought by the DOJ against the company with respect to cost reports and
physician relations. This agreement resolves all remaining investigation issues
between DOJ and the company.

         Upon court approval of the agreement, which was originally announced in
December 2002, HCA will pay the DOJ $631 million plus accrued interest.

         HCA also announced today that the company and the Centers for Medicare
and Medicaid Services have signed an agreement, previously announced in March
2002, to resolve all Medicare cost report, home office cost statement, and
appeal issues between HCA and CMS for cost report periods ending before Aug. 1,
2001. The agreement calls for HCA to pay CMS $250 million within five business
days. This agreement is not subject to court approval, and HCA expects to pay
the settlement amount before July 1, 2003.

         The company also has finalized an agreement with a negotiating team
representing states that may have claims similar to those of DOJ. Under this
agreement, HCA will pay $17.7 million to state Medicaid agencies to resolve
these claims. This agreement was previously announced in December 2002.

         As a result of these settlements, the company recorded an after tax
charge of $468 million in its fourth quarter ended December 31, 2002.



This press release contains forward-looking statements based on management's
current expectations. Numerous risks, uncertainties and other factors may cause
actual results to differ materially from those anticipated in the
forward-looking statements, including: (i) the ability to obtain court approval
of the agreement with the DOJ, (ii) any examination by the Internal Revenue
Service or state tax authorities of the tax treatment of the amounts paid
pursuant to the agreements and any related adjustments, and (iii) other risks
and uncertainties detailed from time to time in the Company's filings with the
Securities and Exchange Commission.



Many of the factors that will determine the Company's future results are beyond
the ability of the Company to control or predict. Readers should not place undue
reliance on forward-looking statements, which reflect management's views only as
of the date hereof. The Company undertakes no obligation to revise or update any
forward-looking statements, or to make any other forward-looking statements,
whether as a result of new information, future events or otherwise.

All references to "company" and "HCA" as used throughout this document refer to
HCA Inc. and its affiliates.